C12N 2502/1388
Mesenchymal stem cells from other natural sources
C12N2502/1388 (Mesenchymal stem cells from other natural sources) appears on 28 US grants and 64 published applications in this corpus.
Search patents in C12N- Granted patents
- 28
- Published applications
- 64
- Assignees
- 57
- Inventors
- 164
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 4 |
| 2008 | 0 | 4 |
| 2009 | 0 | 1 |
| 2010 | 0 | 3 |
| 2011 | 3 | 2 |
| 2012 | 1 | 2 |
| 2013 | 0 | 1 |
| 2014 | 5 | 4 |
| 2015 | 2 | 4 |
| 2016 | 2 | 2 |
| 2017 | 1 | 3 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 2 | 3 |
| 2021 | 2 | 3 |
| 2022 | 1 | 11 |
| 2023 | 0 | 3 |
| 2024 | 0 | 5 |
| 2025 | 5 | 5 |
| 2026 | 2 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Hair follicle primordia and method for producing same16 Jun 2026US 12,655,387 B2Kanagawa Institute of Industrial Science and Technology
- Differentiation of olfactory mucosa derived mesenchymal stem cells to schwann cells for peripheral nerve repair17 Feb 2026US 12,551,506 B2Northeastern University
- Composition for preventing or treating renal diseases, comprising exosomes derived from precursor cells of induced pluripotent stem cell-derived mesenchymal stem cells9 Dec 2025US 12,491,212 B2Brexogen Inc.
- Producing method of mesenchymal stem cell for prevention or treatment of brain neuronal disease including ghrelin treatment and use thereof7 Oct 2025US 12,433,935 B2Samsung Life Public Welfare Foundation
- Immunomodulation by amniotic fluid mesenchymal stem cells7 Oct 2025US 12,435,308 B2Amniotics AB
- Producing method of mesenchymal stem cell for prevention or treatment of brain neuronal disease including ghrelin treatment and use thereof5 Mar 2026US 2026/0061034 A1Samsung Life Public Welfare Foundation
- Methods of making and using immune-tolerized fetal stem cell-derived extracellular vesicles for hair loss treatment8 Jan 2026US 2026/0008998 A1Stemmedicare Co., Ltd.
- Method of increasing stem cell production30 Oct 2025US 2025/0333706 A1The Crowley Center for Rgenerative Biotherapeutics, LLC
- Composition for promoting angiogenesis comprising extracellular vesicles derived from three-dimensional spheroid-type cell aggregate28 Aug 2025US 2025/0268837 A1S & E Bio Corporation
- Composition for sperm treatment, sperm motility improving agent, sperm fertilizing capability retaining agent, sperm motility improving method, and sperm fertilizing capability retaining method5 Jun 2025US 2025/0179426 A1Hiroshima University
Most cited
By later US patents
- Tumor suppression using placental stem cells57US 7,993,918 B2Anthrogenesis Corporation · 2011
- Blood brain barrier device12US 8,900,865 B2The Invention Science Fund I, LLC · 2014
- Method for the preparation of dermal papilla tissue employing mesenchymal stem cells11US 8,017,390 B2Dongguk University Industry-Academic Cooperation Foundation · 2011
- Choroid plexus device11US 8,053,220 B2The Invention Science Fund I, LLC · 2011
- CD34+CD7+CD5+CD1a-human progenitor T-cells produced in vitro and methods of using5US 8,772,028 B2Sunnybrook Health Sciences Centre · 2014